Cargando…

Acetyl-cholinesterase-inhibitors slow cognitive decline and decrease overall mortality in older patients with dementia

We evaluated the effect of Acetyl-cholinesterase-inhibitors (AChEIs) on cognitive decline and overall survival in a large sample of older patients with late onset Alzheimer’s disease (LOAD), vascular dementia (VD) or Lewy body disease (LBD) from a real world setting. Patients with dementia enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuin, Marco, Cherubini, Antonio, Volpato, Stefano, Ferrucci, Luigi, Zuliani, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288483/ https://www.ncbi.nlm.nih.gov/pubmed/35842477 http://dx.doi.org/10.1038/s41598-022-16476-w

Ejemplares similares

Combining LDL-C and HDL-C to predict survival in late life: The InChianti study
por: Zuliani, Giovanni, et al.
Publicado: (2017)

Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality
por: Xu, Hong, et al.
Publicado: (2021)

Memantine combined with an acetyl cholinesterase inhibitor – hope for the future?
por: Fox, Chris, et al.
Publicado: (2006)

DUAL DECLINE IN MEMORY AND GAIT UNIQUELY IDENTIFIES OLDER PERSONS AT HIGH RISK OF DEMENTIA
por: Tian, Qu, et al.
Publicado: (2019)

RBC acetyl cholinesterase: A poor man's early diagnostic biomarker for familial alzheimer's and Parkinson's disease dementia
por: Bawaskar, Himmatrao Saluba, et al.
Publicado: (2015)

Concomitant Cholinesterase Inhibitor and Anticholinergic Drug Use Among Older Adults With Dementia
por: Carter, Elizabeth, et al.
Publicado: (2020)

Acetyl and butyryl cholinesterase inhibitory sesquiterpene lactones from Amberboa ramosa
por: Ibrahim, Muhammad, et al.
Publicado: (2013)

Role of Muscle Mass and Muscle Quality in the Association Between Diabetes and Gait Speed
por: Volpato, Stefano, et al.
Publicado: (2012)

Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease
por: Khan, Mohd. Babu, et al.
Publicado: (2018)

Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
por: Rountree, Susan D, et al.
Publicado: (2009)

Risk of dementia in patients with atrial fibrillation: Short versus long follow‐up. A systematic review and meta‐analysis
por: Zuin, Marco, et al.
Publicado: (2021)

Association of Dual Decline in Memory and Gait Speed With Risk for Dementia Among Adults Older Than 60 Years: A Multicohort Individual-Level Meta-analysis
por: Tian, Qu, et al.
Publicado: (2020)

Left Bundle Branch Block and Mortality in COVID-19 Patients
por: Zuin, Marco, et al.
Publicado: (2021)

Serum Acetyl Cholinesterase as a Biomarker of Arsenic Induced Neurotoxicity in Sprague-Dawley Rats
por: Patlolla, Anita K., et al.
Publicado: (2005)

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia
por: Hoffmann, Falk, et al.
Publicado: (2011)

Cholinesterase inhibitors for the treatment of dementia: real-life data in Hungary
por: Balázs, Nóra, et al.
Publicado: (2021)

Mortality risk in COVID-19 patients with right bundle branch block
por: Zuin, Marco, et al.
Publicado: (2021)

Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead
por: Zuin, Marco, et al.
Publicado: (2021)

Dual Decline in Gait and Cognition Is Associated With Future Dementia: Evidence for a Phenotype
por: Odasso, Manuel Montero, et al.
Publicado: (2020)

Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase – Design, synthesis and biological evaluation
por: Remya, Chandran, et al.
Publicado: (2021)

Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
por: Meng, Yan-Hong, et al.
Publicado: (2019)

OUTCOMES OF DISCONTINUING CHOLINESTERASE INHIBITORS IN NURSING HOME RESIDENTS WITH SEVERE DEMENTIA
por: Niznik, Joshua D, et al.
Publicado: (2019)

Effects of cholinesterase inhibition on attention and working memory in Lewy body dementias
por: Fallon, Sean James, et al.
Publicado: (2023)

Characteristics of Nondisabled Older Patients Developing New Disability Associated with Medical Illnesses and Hospitalization
por: Volpato, Stefano, et al.
Publicado: (2007)

Serum Leptin and Risk of Cognitive Decline in Elderly Italians
por: Littlejohns, Thomas J., et al.
Publicado: (2015)

Predictive Value of Admission N-Terminal Pro-B-Type Natriuretic Peptide and Renal Function in Older People Hospitalized for Dyspnoea
por: Fabbian, Fabio, et al.
Publicado: (2013)

COVID-19 Patients With Previous Coronary Artery By-Pass Graft Have a Higher Mortality Risk
por: Zuin, Marco, et al.
Publicado: (2021)

Chemical Compositionand Anti-acetyl cholinesterase Activity of Flower Essential Oils of Artemisiaannuaat Different Flowering Stage
por: Yu, Zhengwen, et al.
Publicado: (2011)

Annurca Apple Polyphenol Extract Affects Acetyl- Cholinesterase and Mono-Amine Oxidase In Vitro Enzyme Activity
por: Nasso, Rosarita, et al.
Publicado: (2021)

Persistence of Cholinesterase Inhibitor Treatment in Dementia: Insights from a Naturalistic Study
por: Olazarán, Javier, et al.
Publicado: (2013)

Cholinesterase Research
por: Korabecny, Jan, et al.
Publicado: (2021)

Increased interest in acute pulmonary embolism in Italy during the COVID-19 pandemic: a google trends-based analysis
por: Roncon, Loris, et al.
Publicado: (2020)

Can Activation of Acetylcholinesterase by β-Amyloid Peptide Decrease the Effectiveness of Cholinesterase Inhibitors?
por: Zueva, Irina V., et al.
Publicado: (2023)

Adverse events in older adults and the risk of dementia and cognitive decline
por: Nilaweera, Dinuli, et al.
Publicado: (2023)

Comparative Kinetics of Acetyl- and Butyryl-Cholinesterase Inhibition by Green Tea Catechins|Relevance to the Symptomatic Treatment of Alzheimer’s Disease
por: Okello, Edward J., et al.
Publicado: (2020)

Proteomic Mediators of Overall Cardiovascular Health on All-Cause Mortality
por: Tanaka, Toshiko, et al.
Publicado: (2023)

Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients
por: Zuin, Marco, et al.
Publicado: (2021)

Plasma metabolomic signatures of dual decline in memory and gait in older adults
por: Tian, Qu, et al.
Publicado: (2023)

Association of Vision Impairment With Cognitive Decline Across Multiple Domains in Older Adults
por: Varadaraj, Varshini, et al.
Publicado: (2021)

Adverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and Canada
por: Ali, Thibault B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1lmuq9dkq142scg5c121pgs3ot